Lobbying activity

Q1

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION for PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate

Health Issues, Manufacturing, Pharmacy

View → Q1

VENABLE LLP for MEDISCA INC.

1st Quarter (Jan 1 - Mar 31) 2025 · New York · $60,000.00 income

Pharmacy

View → Q1

AARP for AARP

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Agriculture, Law Enforcement/Crime/Criminal Justice

View → Q1

VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $30,000.00 income

Consumer Issues/Safety/Products, Pharmacy

View → Q1

HARMONY BIOSCIENCES for HARMONY BIOSCIENCES

1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate

Pharmacy

View → Q1

BALLARD PARTNERS for THE CRANEWARE GROUP (F.K.A. SENTRY DATA SYSTEMS)

1st Quarter (Jan 1 - Mar 31) 2025 · Florida · House · Senate · $50,000.00 income

Health Issues, Pharmacy

View → Q1

KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Defense

View → RA

STEPTOE LLP for AQUESTIVE THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey

Health Issues, Pharmacy

View → Q1

SQUIRE PATTON BOGGS for SK AMERICAS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $220,000.00 income

Environment/Superfund, Pharmacy, Science/Technology, Taxation/Internal Revenue Code

View → RR

FRONTLINE GOVERNMENT RELATIONS for EMPOWER PHARMACY

2nd Quarter (Apr 1 - June 30) 2025 · Texas

Pharmacy, Health Issues, Medical/Disease Research/Clinical Labs

View → Q1

WINNING STRATEGIES WASHINGTON for KALEO

1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $10,000.00 income

Health Issues, Pharmacy, Defense, Budget/Appropriations

View → Q1

FOLEY & LARDNER LLP for FOUNDATION CONSUMER HEALTHCARE LLC

1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $120,000.00 income

Pharmacy, Health Issues

View → 1T

THORN RUN PARTNERS for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $30,000.00 income

Health Issues, Pharmacy, Medicare/Medicaid

View → Q1

THORN RUN PARTNERS for OTSUKA AMERICA PHARMACEUTICAL, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate · $50,000.00 income

Taxation/Internal Revenue Code, Pharmacy, Health Issues

View → Q1

MASSACHUSETTS MEDICAL SOCIETY for MASSACHUSETTS MEDICAL SOCIETY

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate

Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Immigration

View → Q1

HANCE SCARBOROUGH for ALLIANCE FOR PHARMACY COMPOUNDING

1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $50,000.00 income

Health Issues, Pharmacy, Budget/Appropriations

View → Q1

SUSAN B ANTHONY LIST for SUSAN B ANTHONY LIST

1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate

Medical/Disease Research/Clinical Labs, Insurance, Medicare/Medicaid, Pharmacy

View → Q1

FOLEY & LARDNER LLP for BLINK HEALTH LTD (A BERMUDA LIMITED COMPANY)

1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $80,000.00 income

Health Issues, Pharmacy

View → Q1

SIMS STRATEGIES, LLC for GLAXOSMITHKLINE, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $40,000.00 income

Pharmacy, Medicare/Medicaid

View → Q1

FEROX STRATEGIES for VIATRIS INC

1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $70,000.00 income

Pharmacy, Foreign Relations

View → Q1

FOLEY & LARDNER LLP for ASSOCIATION FOR ACCESSIBLE MEDICINES

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Pharmacy, Trade (domestic/foreign), Manufacturing

View → Q1

UC HEALTH for UC HEALTH

1st Quarter (Jan 1 - Mar 31) 2025 · Ohio · House · Senate

Medicare/Medicaid, Defense, Pharmacy

View → Q1

FEROX STRATEGIES for FRESENIUS KABI USA LLC

1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $50,000.00 income

Health Issues, Pharmacy

View → Q1

FEROX STRATEGIES for ELI LILLY AND COMPANY

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy

View → Q1

FOLEY & LARDNER LLP for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY

1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $70,000.00 income

Pharmacy, Health Issues

View →